stock

Incyte Corp. (INCY)

0

Share

Stay up to date

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics.

Financial Statements

Key Info

  • Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
  • Sector: Professional, Scientific, and Technical Services
  • CEO Name: Paul Friedman

Key Statistics

  • Stock Price: $68.78
  • Dividend Yield: 0%
  • Market Capitalization: $15,164,757,922
  • Shares Outstanding: 220,835,269
  • Number of Employees: 1,773
  • Trailing 12-Month EPS: $1.54
  • Trailing 12-Month DPS: $0
  • Payout Ratio: 0.0%

Important Dates

  • Next Earnings Date: 2021-11-02
  • Next Ex-Dividend Date:

Price Trends

  • Current Stock Price: $68.78
  • 52-week high: $101.47
  • 52-week low: $67.87
  • 200-day moving average: $79.79
  • 50-day moving average: $73.8

Performance

  • 1-Month Price Return: -9.3%
  • 3-Month Price Return: -18.9%
  • 6-Month Price Return: -15.3%
  • 1-Year Price Return: -21.5%
  • 2-Year Price Return: -5.7%
  • 5-Year Price Return: -25.6%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast